Publicaciones en colaboración con investigadores/as de Erasmus University Medical Center (6)

2024

  1. An illness–death multistate model to implement delta adjustment and reference-based imputation with time-to-event endpoints

    Pharmaceutical Statistics, Vol. 23, Núm. 2, pp. 219-241

  2. Prediction of individual lifetime cardiovascular risk and potential treatment benefit: Development and recalibration of the LIFE-CVD2 model to four European risk regions

    European Journal of Preventive Cardiology, Vol. 31, Núm. 14, pp. 1690-1699

2023

  1. A Flexible Analytical Framework for Reference-Based Imputation, Delta Adjustment and Tipping-Point Stress-Testing

    Statistics in Biopharmaceutical Research, Vol. 15, Núm. 4, pp. 781-793

2022

  1. Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses

    Circulation, Vol. 146, Núm. 20, pp. 1507-1517

2020

  1. MMRM vs joint modeling of longitudinal responses and time to study drug discontinuation in clinical trials using a “de jure” estimand

    Pharmaceutical Statistics, Vol. 19, Núm. 6, pp. 909-927

2014

  1. FGF receptor genes and breast cancer susceptibility: Results from the Breast Cancer Association Consortium

    British Journal of Cancer, Vol. 110, Núm. 4, pp. 1088-1100